Bifidobacterium longum subsp. infantis M-63
Bifidobacterium longum subsp. infantis (B. infantis) is associated with improved growth, the development of intestinal membrane integrity, and is critical for developing immune function.*
The Developing Intestinal Microflora of Newborns Is Up to 90% B. Infantis
B. infantis is the predominant intestinal organism found in breast-fed infants.* B. infantis M-63 was isolated from a healthy infant and clinically proven to colonize the intestines of infants.*
B. infantis is the only bacterial species able to take up and metabolize all Human Milk Oligosaccharides (HMOs) which allows B. infantis to outcompete other bacterial species.*
Jarro-Dophilus® Infant is formulated with Medium Chain Triglycerides (MCTs), which are naturally present in breast milk and are more easily absorbed by the newborn’s immature digestive system.*
When it comes to effective probiotics, clinically documented Strains Matter™.